HealthDay operates under the strictest editorial standards. Our syndicated news content is completely independent of any financial interests, is based solely on industry-respected sources and the latest scientific research, and is carefully fact-checked by a
team of industry experts to ensure accuracy.
- All articles are edited and checked for factual accuracy by our
Editorial Team prior to being published.
- Unless otherwise noted, all articles focusing on new research are based on studies published in
peer-reviewed journals or issued from independent and respected medical associations, academic groups and governmental organizations.
- Each article includes a link or reference to the original source.
- Any known potential conflicts of interest associated with a study or source are made clear to the reader.
Please see our
Editorial and Fact-Checking Policy for more detail.
Editorial and Fact-Checking Policy
HealthDay Editorial Commitment
HeathDay is committed to maintaining the highest possible levels of impartial editorial standards in the content that we present on our website. All of our articles are chosen independent of any financial interests. Editors and writers make all efforts to clarify any financial ties behind the studies on which we report.
Iron metabolism seems tied to metabolic-associated fatty liver disease (MAFLD). An analysis of open genome-wide association study databases showed that elevated liver iron was associated with increased MAFLD risk, and genetically predicted MAFLD was associated with increased serum ferritin levels.
The content contained in this article is over two years old. As such our recommendation is that you reference the articles below for the latest updates on this topic. This article has been left on our site as a matter of historic record. Please contact us at email@example.com with any questions.